TSS
FLNA

Two Sigma Securities’s Filana Therapeutics FLNA Stock Holding History

Two Sigma Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,696
Closed -$21.5K – 2273
2026
Q1 		$21.5K Buy
+12,696
New +$26.1K ﹤0.01% 1364
2025
Q2 		– Sell
-17,694
Closed -$26.5K – 2004
2025
Q1 		$26.5K Buy
+17,694
New +$44.7K ﹤0.01% 1064
2019
Q2 		– Sell
-10,558
Closed -$14K – 2374
2019
Q1 		$14K Buy
+10,558
New +$12.1K ﹤0.01% 1701
2017
Q3 		– Sell
-10,587
Closed -$44K – 1182
2017
Q2 		$44K Buy
10,587
+1,793
+20% +$8.46K 0.01% 730
2017
Q1 		$55K Buy
8,794
+3,804
+76% +$17.3K 0.01% 797
2016
Q4 		$20K Sell
4,990
-180
-3% -$835 0.01% 652
2016
Q3 		$36K Buy
+5,170
New +$85.7K 0.01% 575

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Two Sigma Securities's FLNA Position: Q2 2026 in Review

Two Sigma Securities sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 12,696 shares — an estimated $21.5K sold.

Two Sigma Securities first reported a position in FLNA in Q3 2016 and held it in 7 quarters. The position peaked at $55K in Q1 2017. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Two Sigma Securities reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,696 Filana Therapeutics shares in Q2 2026, an estimated $21.5K.
  • Two Sigma Securities first reported a position in Filana Therapeutics in Q3 2016 and held it in 7 quarters.
  • Two Sigma Securities's Filana Therapeutics position peaked at $55K in Q1 2017.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.